DISCGENICS
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
DISCGENICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2007-11-06
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.discgenics.com
Total Employee:
11+
Status:
Active
Contact:
801-410-0703
Total Funding:
68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx PHP
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Employees Featured
Rand Page Investor @ DiscGenics
Investor
Flagg Flanagan Chairman & CEO @ DiscGenics
Chairman & CEO
John Robertson Founder @ DiscGenics
Founder
Mark Cohen Founder @ DiscGenics
Founder
Kevin T. Foley Director & Chief Medical Officer @ DiscGenics
Director & Chief Medical Officer
2008-08-01
Bob Wynalek Director and Chief Operating & Commercialization Officer @ DiscGenics
Director and Chief Operating & Commercialization Officer
Jeff Poole Chief Financial Officer @ DiscGenics
Chief Financial Officer
2020-08-01
Mike Moffat Former Executive Officer @ DiscGenics
Former Executive Officer
Valery Kukekov Founder @ DiscGenics
Founder
Founder
Investors List
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series C - DiscGenics
Medical Incubator Japan
Medical Incubator Japan investment in Series C - DiscGenics
Ci:z Investment
Ci:z Investment investment in Series C - DiscGenics
Najeeb Thomas
Najeeb Thomas investment in Series C - DiscGenics
Eagle Venture Fund
Eagle Venture Fund investment in Series C - DiscGenics
CareNet
CareNet investment in Series C - DiscGenics
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series B - DiscGenics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-09-09 | DiscGenics Appoints Former Medtronic Spine and Biologics Finance Executive as First Chief Financial Officer |
Official Site Inspections
http://www.discgenics.com Semrush global rank: 2.23 M Semrush visits lastest month: 8.66 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "DiscGenics"
Our Company - DiscGenics
DiscGenics, a pioneer in regenerative medicine, has made significant advancements in treating degenerative spine diseases thanks to its visionary founders. Co-founded in 2008 by Dr. …See details»
DiscGenics - Crunchbase Company Profile & Funding
Organization. DiscGenics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Our Focus — DiscGenics
At DiscGenics, we are focused on developing regenerative cell-based biologic drug therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. As major contributors to low back pain, …See details»
DiscGenics
The DiscGenics team is full of smart and dedicated individuals all working to provide a cutting-edge therapy for patients. Every day is engaging and exciting, full of learning and growth. I get …See details»
DiscGenics - LinkedIn
DiscGenics | 3,187 followers on LinkedIn. REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN | DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative ...See details»
Discgenics, Inc. Company Profile | Salt Lake City, UT | Competitors ...
Find company research, competitor information, contact details & financial data for Discgenics, Inc. of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»
DiscGenics 2025 Company Profile: Valuation, Funding …
DiscGenics was founded in 2008. Where is DiscGenics headquartered? DiscGenics is headquartered in Salt Lake City, UT. What is the size of DiscGenics? DiscGenics has 42 total employees. What industry is DiscGenics …See details»
DiscGenics - VentureRadar
DiscGenics is harnessing the restorative potential of intervertebral disc cells to develop therapies that the company believes will have a profound impact on millions suffering from the …See details»
DiscGenics Company Profile - Office Locations, Competitors ... - Craft
DiscGenics is a biopharmaceutical company focused on developing regenerative therapies aimed at alleviating pain and restoring function in patients with diseases of the spine. Its product …See details»
What Happened To DiscGenics, Co-Founded By 'Dr.
Jul 15, 2021 DiscGenics’ current funding amount is $68 million. "Dr. Death" is available to stream on Peacock now. And if you want to dive even deeper into the story, you can also watch the new docuseries "Dr. Death: The Undoctored …See details»
DiscGenics - Funding, Financials, Valuation & Investors - Crunchbase
DiscGenics is funded by 5 investors. Mitsubishi UFJ Capital and Medical Incubator Japan are the most recent investors. Which investors participated in the most funding rounds?See details»
Investors & Media - DiscGenics
Feb 8, 2024 DiscGenics has gained acceptance from the U.S. FDA for the clinical protocols and Chemistry, Manufacturing, and Controls (CMC) clinical development plan for Phase III clinical …See details»
DiscGenics - Contacts, Employees, Board Members, Advisors
Organization. DiscGenics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 9. Number of Board …See details»
New Cell Therapy Could Help Millions Suffering from Back Pain
May 30, 2018 DiscGenics engages CCRM and GE Healthcare to support scale-up efforts for new cell therapy. May 30, 2018 (Toronto, ON, Salt Lake City, UT) -- Degenerative disc disease …See details»
DISCGENICS: 10 in 10 Podcast - Merge Medical
Jul 10, 2023 DiscGenics is committed to revolutionizing the way millions of patients suffering from chronic back pain will be treated through a focus on developing regenerative therapies …See details»
DiscGenics Announces US FDA Approval to Proceed with Phase III …
Jul 23, 2024 DiscGenics is a privately held, late-stage clinical biopharmaceutical company developing allogeneic, cell-based regenerative therapies for musculoskeletal degeneration.See details»
FDA-Approved Study of an Allogeneic Disc Progenitor Cell …
Jul 9, 2024 DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, …See details»
DiscGenics - Golden
DiscGenics is led by a team of medical device and biologics industry executives, practicing clinicians and innovators in orthopedics, spinal and neurosurgical markets. DiscGenics is …See details»
Discogenic Cells — DiscGenics
DiscGenics’ cell isolation and manufacturing process is protected globally by over 40 issued patents and 30 additional patents pending, and is trade secret protected. Scientific …See details»
DNA organization offers clues for advancing stem cell therapy
4 days ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll …See details»